Brief: Jacobio Pharmaceuticals Says Revenue Of Rmb40.3 Million For Six Months
30/08/2023 16:48
Aug 30 (Reuters) - Jacobio Pharmaceuticals Group Co Ltd
1167.HK :
* REVENUE OF RMB40.3 MILLION FOR SIX MONTHS
* HY LOSS INCREASED FROM RMB127.8 MILLION TO RMB166.3
MILLION
Source text for Eikon: ID:nHKS8Z4Nmb
Further company coverage: 1167.HK
Recent news on Jacobio Pharmaceuticals
See all newsBrief: Jacobio Pharmaceuticals Appoints Xiaojie Wang As Vice Chairperson
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan